US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 4.350
  • +0.320+7.94%
Close Dec 20 16:00 ET
  • 4.350
  • 0.0000.00%
Post 18:05 ET
234.63MMarket Cap-15.00P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
8,990.91%80M
0
-55.77%2.81M
27.15%871K
-35.84%759K
-53.24%880K
-88.62%295K
-66.90%6.34M
-86.46%685K
Operating revenue
--0
8,990.91%80M
--0
-55.77%2.81M
27.15%871K
-35.84%759K
-53.24%880K
-88.62%295K
-66.90%6.34M
-86.46%685K
Cost of revenue
Gross profit
Operating expense
-18.21%23.06M
-2.36%27.51M
5.66%29.83M
-4.23%113.47M
0.58%28.86M
12.47%28.2M
-22.00%28.17M
-1.24%28.24M
18.22%118.48M
0.28%28.7M
Selling and administrative expenses
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
2.62%9.96M
-6.98%10.32M
7.07%11.52M
36.63%41.69M
4.38%10.13M
-General and administrative expense
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
2.62%9.96M
-6.98%10.32M
7.07%11.52M
36.63%41.69M
4.38%10.13M
Research and development costs
-19.73%14.64M
-3.29%17.26M
18.29%19.77M
-6.49%71.8M
2.33%19M
18.69%18.24M
-28.66%17.85M
-6.26%16.72M
10.16%76.78M
-1.83%18.57M
Operating profit
15.95%-23.06M
292.33%52.49M
-6.78%-29.83M
1.31%-110.66M
0.07%-27.99M
-14.86%-27.44M
20.28%-27.29M
-7.47%-27.94M
-38.34%-112.13M
-18.90%-28.01M
Net non-operating interest income expense
Other net income (expense)
-60.06%1.37M
-16.87%2.92M
-6.23%2.96M
489.00%13.33M
72.49%3.24M
2,151.97%3.42M
2,026.67%3.51M
4,415.71%3.16M
993.24%2.26M
2,401.33%1.88M
Special income (charges)
---2.06M
----
----
--0
--0
--0
----
----
---427K
--38K
-Less：Restructuring and merger&acquisition
--2.06M
----
----
--0
--0
--0
----
----
--427K
---38K
Other non- operating income (expenses)
0.20%3.43M
-16.87%2.92M
-6.23%2.96M
395.50%13.33M
76.06%3.24M
454.78%3.42M
2,026.67%3.51M
4,415.71%3.16M
1,199.52%2.69M
2,350.67%1.84M
Income before tax
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Income tax
Net income
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Net income continuous Operations
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Minority interest income
Net income attributable to the parent company
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Basic earnings per share
10.26%-0.35
334.21%0.89
-4.88%-0.43
34.84%-1.59
20.00%-0.4
23.53%-0.39
54.22%-0.38
35.94%-0.41
-6.55%-2.44
13.79%-0.5
Diluted earnings per share
10.26%-0.35
328.95%0.87
-4.88%-0.43
34.84%-1.59
20.00%-0.4
23.53%-0.39
54.22%-0.38
35.94%-0.41
-6.55%-2.44
13.79%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 08,990.91%80M0-55.77%2.81M27.15%871K-35.84%759K-53.24%880K-88.62%295K-66.90%6.34M-86.46%685K
Operating revenue --08,990.91%80M--0-55.77%2.81M27.15%871K-35.84%759K-53.24%880K-88.62%295K-66.90%6.34M-86.46%685K
Cost of revenue
Gross profit
Operating expense -18.21%23.06M-2.36%27.51M5.66%29.83M-4.23%113.47M0.58%28.86M12.47%28.2M-22.00%28.17M-1.24%28.24M18.22%118.48M0.28%28.7M
Selling and administrative expenses -15.43%8.42M-0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M2.62%9.96M-6.98%10.32M7.07%11.52M36.63%41.69M4.38%10.13M
-General and administrative expense -15.43%8.42M-0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M2.62%9.96M-6.98%10.32M7.07%11.52M36.63%41.69M4.38%10.13M
Research and development costs -19.73%14.64M-3.29%17.26M18.29%19.77M-6.49%71.8M2.33%19M18.69%18.24M-28.66%17.85M-6.26%16.72M10.16%76.78M-1.83%18.57M
Operating profit 15.95%-23.06M292.33%52.49M-6.78%-29.83M1.31%-110.66M0.07%-27.99M-14.86%-27.44M20.28%-27.29M-7.47%-27.94M-38.34%-112.13M-18.90%-28.01M
Net non-operating interest income expense
Other net income (expense) -60.06%1.37M-16.87%2.92M-6.23%2.96M489.00%13.33M72.49%3.24M2,151.97%3.42M2,026.67%3.51M4,415.71%3.16M993.24%2.26M2,401.33%1.88M
Special income (charges) ---2.06M----------0--0--0-----------427K--38K
-Less：Restructuring and merger&acquisition --2.06M----------0--0--0----------427K---38K
Other non- operating income (expenses) 0.20%3.43M-16.87%2.92M-6.23%2.96M395.50%13.33M76.06%3.24M454.78%3.42M2,026.67%3.51M4,415.71%3.16M1,199.52%2.69M2,350.67%1.84M
Income before tax 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Income tax
Net income 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Net income continuous Operations 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Minority interest income
Net income attributable to the parent company 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Basic earnings per share 10.26%-0.35334.21%0.89-4.88%-0.4334.84%-1.5920.00%-0.423.53%-0.3954.22%-0.3835.94%-0.41-6.55%-2.4413.79%-0.5
Diluted earnings per share 10.26%-0.35328.95%0.87-4.88%-0.4334.84%-1.5920.00%-0.423.53%-0.3954.22%-0.3835.94%-0.41-6.55%-2.4413.79%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List